Cantor Fitzgerald downgraded NextGen Healthcare to Neutral from Overweight with a $23.95 price target after the company agreed to be acquired by Thoma Bravo for $23.95 per share.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See today’s best-performing stocks on TipRanks >>
Read More on NXGN:
- NextGen Healthcare downgraded to Neutral from Buy at Guggenheim
- NextGen Healthcare downgraded to Equal Weight from Overweight at Stephens
- NextGen (NASDAQ:NXGN) Jumps on Acquisition Deal with Thoma Bravo
- NextGen Healthcare to be acquired by Thoma Bravo for $23.95 per share in cash
- Thoma Bravo in advanced talks to buy NextGen Healthcare, Bloomberg says
